| 000 | 01551 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515161410.0 | ||
| 264 | 0 | _c20090423 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1532-4192 | ||
| 024 | 7 |
_a10.1080/07357900802438585 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOdonkor, Charles A | |
| 245 | 0 | 0 |
_aModulation of effector caspase cleavage determines response of breast and lung tumor cell lines to chemotherapy. _h[electronic resource] |
| 260 |
_bCancer investigation _cMay 2009 |
||
| 300 |
_a417-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xenzymology |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCaspase 7 _xmetabolism |
| 650 | 0 | 4 | _aCaspase Inhibitors |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xenzymology |
| 650 | 0 | 4 |
_aPaclitaxel _xpharmacology |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aAchilefu, Samuel | |
| 773 | 0 |
_tCancer investigation _gvol. 27 _gno. 4 _gp. 417-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/07357900802438585 _zAvailable from publisher's website |
| 999 |
_c18683118 _d18683118 |
||